Loading...
Sutent
Antineoplastic • Multi-kinase inhibitor
Half-life
40-60 hours (80-110 hours for active metabolite)
Protein Binding
95%
Metabolized By
CYP3A4
External
Drugs.comInhibits multiple receptor tyrosine kinases (VEGFR, PDGFR, KIT, FLT3, RET)
Drug Class
Antineoplastic
Subclass
Multi-kinase inhibitor
Half-life
40-60 hours (80-110 hours for active metabolite)
Time for plasma concentration to decrease by 50%
Protein Binding
95%
Fraction bound to plasma proteins
Therapeutic Index
Wide
Margin between therapeutic and toxic doses